Eli Lilly & Co. vs Medline Inc.
LLY vs MDLN — side-by-side comparison from reported financials. LLY leads 9, MDLN leads 1 of 10 comparable metrics.
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
Medline Inc.
MDLN · Healthcare
$36.29+1.54%Solid
| Metric | LLY | MDLN |
|---|---|---|
| Price | $1 177.20 | $36.29 |
| Market cap | $1.05T | $31.8B |
| Revenue (TTM) | $79.7B | $29.9B |
| Revenue growth | +31.7% | +9.8% |
| Net margin | 33.5% | 1.7% |
| Free cash flow | $18.2B | $1.58B |
| Net cash (debt) | ($35.2B) | ($10.6B) |
| 1-year price return | +37.6% | — |
| P/E | 41.6 | 68.8 |
| P/E vs own history (cheap-side %) | 88% | 15% |
| Dividend yield | 0.52% | — |
| Return on equity | 93% | 5% |
| Altman Z-score | 7.10 | 1.65 |
| CV checks passed | 11 of 11 | 5 of 11 |
| Employees | 50,000 | 45,000 |
Full résumé-style profiles: LLY CV · MDLN CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.